CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Huang J, Chen P, Liu K, Liu J, Zhou B, Wu R, Peng Q, Liu ZX, Li C, Kroemer G, Lotze M, Zeh H, Kang R, Tang D.
Huang J, et al. Among authors: li c.
Gut. 2021 May;70(5):890-899. doi: 10.1136/gutjnl-2019-320441. Epub 2020 Aug 14.
Gut. 2021.
PMID: 32816920